Welcome to our dedicated page for Netcapital news (Ticker: NCPL), a resource for investors and traders seeking the latest updates and insights on Netcapital stock.
Netcapital Inc. reports developments in fintech services for private capital formation. The company operates an online platform that allows private companies to raise capital digitally and gives investors access to private equity opportunities. Its funding portal, Netcapital Funding Portal, Inc., is registered with the SEC and is a FINRA member, and its broker-dealer, Netcapital Securities Inc., is also SEC-registered and a FINRA member.
Company updates commonly cover platform strategy, financial results, governance changes, equity compensation, and capital actions. Recent themes also include digital asset and tokenization initiatives, the completed acquisition of Iverson Design assets, and the addition of AI-driven design, animation, visualization, and real-time rendering technology to support issuer presentations and platform development.
Netcapital Inc. (OTC: NCPL) has partnered with Rialto Markets to enhance private capital market dynamics. This collaboration leverages Rialto's alternative trading system (ATS) and blockchain technology to improve distribution and liquidity for issuers and investors. Rialto aims to scale its issuer volume and increase profitability through this agreement. Both companies anticipate significant benefits, including greater demand and potential share price increases for Netcapital, as they focus on the accelerating growth in digital private capital markets.
Netcapital Inc. (OTC: NCPL) announced its partnership with C-Reveal Therapeutics to enhance cancer treatment through a novel immune response mechanism. Netcapital has acquired an equity stake in C-Reveal, which is currently fundraising to support its innovative immuno-oncology approaches. C-Reveal aims to enable the immune system to effectively target cancer cells by inhibiting enzymes that hide the disease. This partnership is backed by seasoned professionals in oncology and aims to attract major pharmaceutical firms for strategic collaborations.
Netcapital Inc. (OTC: NCPL) reported a remarkable 198% increase in revenues for the first half of 2021, totaling $2,493,486. The company also achieved a 71% gross profit margin and positive shareholders' equity of $760,012, up 19% year-over-year. Its investment portfolio surged 186% year-over-year to $3,721,514. Additionally, Netcapital's merger agreement with its partner aims to solidify its position in the fintech sector, along with becoming Penny Stock Exempt. The company experienced significant growth in user engagement and capital investment, highlighting its operational scalability.